Shinsuke Okada
Nagoya City University
37 Papers
83 Citations
Shinsuke Okada is an academic researcher from Nagoya City University. The author has contributed to research in topics: Medicine & Ureteroscopy. The author has an hindex of 8, co-authored 27 publications.
Chat about Author
Papers
Urinary Bladder Cancer: Diffusion-weighted MR Imaging—Accuracy for Diagnosing T Stage and Estimating Histologic Grade
Mitsuru Takeuchi,Shigeru Sasaki,Masato Ito,Shinsuke Okada,Satoru Takahashi,Tatsuya Kawai,Kaori Suzuki,Hidekazu Oshima,Masaki Hara,Yuta Shibamoto +9 more
TL;DR: DW images provided useful information for evaluating the T stage of bladder cancer, particularly in differentiating T1 or lower tumors from T2 or higher tumors.
355
Ureteral Wall Thickness as a Preoperative Indicator of Impacted Stones in Patients with Ureteral Stones Undergoing Ureteroscopic Lithotripsy.
Takashi Yoshida,Takaaki Inoue,Naoto Omura,Shinsuke Okada,Shuzo Hamamoto,Hidefumi Kinoshita,Tadashi Matsuda +6 more
TL;DR: High UWT is associated not only with a higher risk of impacted stones but also with poor endoscopic findings and adverse surgical outcomes in patients with ureteral stones undergoing URSL.
66
Altered distribution of interstitial cells in the guinea pig bladder following bladder outlet obstruction
TL;DR: The increased population of ICs was demonstrated in the BOO guinea-pig model for the first time, and it is suggested that the altered distribution ofICs may contribute to the pathophysiology of bladder overactivity.
61
Retrograde intrarenal surgery: Past, present, and future.
TL;DR: A review of the past, present, and future of retrograde intra-renal surgery can be found in this paper, which provides many topics and clinical options for urologists to consider.
Peroxisome proliferator-activated receptor-γ and growth inhibition by its ligands in prostate cancer
Daisuke Nagata,Hashimoto Yoshihiro,Makoto Nakanishi,Hiromichi Naruyama,Shinsuke Okada,Ryosuke Ando,Keiichi Tozawa,Kenjiro Kohri +7 more
TL;DR: Results suggest that PPAR-gamma ligands may be a useful therapeutic agent for the treatment of prostate cancer.
29